Which blood thinner do bladder cancer patients prefer after surgery?
NCT ID NCT06243510
First seen Jan 31, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study looks at two blood thinners (apixaban and enoxaparin) given to bladder cancer patients after surgery to remove their bladder. The goal is to see which one patients are more likely to take as prescribed, which they prefer, and how much each costs them. About 90 adults with bladder cancer will be randomly assigned to one of the two medications and will take it at home for 30 days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.